All News CH Biotech R&D Co., Ltd.

Equities

6534

TW0006534001

End-of-day quote Taiwan S.E. Other stock markets 18:00:00 2024-06-20 EDT			5-day change	1st Jan Change
84.5 ^TWD	+0.36%		+1.32%	+4.97%

05-21	Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members	CI
05-21	CH Biotech R&D Co., Ltd. Announces Audit Committee Changes	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members	05-21	CI
CH Biotech R&D Co., Ltd. Announces Audit Committee Changes	05-21	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index	03-06	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Second Half of 2023, Payable on April 12, 2024	02-27	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the First Half Ended June 30, 2023, Payable on October 18, 2023	23-08-08	CI
CH Biotech R&D Co., Ltd. Appoints Robert James Christopher Clayton as Institutional Director Representative	23-05-24	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
CH Biotech R&D Co., Ltd. Announces Resignation of Brent Randall Smith as Natural-Person Director	23-03-12	CI
CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director	23-03-02	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Year Ended December 31, 2022, Payable on April 10, 2023	23-02-21	CI
CH Biotech R&D Co., Ltd.(TPEX:6534) added to S&P Global BMI Index	22-09-19	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-01	CI
Ch Biotech R&D Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News CH Biotech R&D Co., Ltd.

Equities

6534

TW0006534001

All News

Filters